Squamous Non-Small Cell Neoplasm of Lung
1 clinical trials · Condition
◉ Watch Squamous Non-Small Cell Neoplasm of Lung
| Record | Firm | Date |
|---|---|---|
| A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer (NCT05275673) | Faeth Therapeutics | 2022-07-21 |
Track Squamous Non-Small Cell Neoplasm of Lung automatically
Every clearance here is in the API, with alerts when new ones post.